FDA Adverse Event Injury Summary report: N

HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE

MDR report key: 1155343 · Received September 5, 2008

Report

Report Number
2025587-2008-00082
Event Type
Injury
Date Received
September 5, 2008
Date of Event
January 28, 2008
Report Date
September 5, 2008
Manufacturer
MEDTRONIC HEART VALVES, INC.
Product Code
LWR
PMA / PMN Number
P980043
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION METHOD: ECHOCARDIOGRAM REVIEWED. CONCLUSION: IT WAS REPORTED THAT THE PRODUCT WILL NOT BE RETURNED FOR ANALYSIS, AND ATTEMPTS TO OBTAIN DEVICE SPECIFIC INFO HAVE BEEN UNSUCCESSFUL. HOWEVER, REVIEW OF ECHOCARDIOGRAMS SUGGEST THAT THE UNDERLYING ROOT CAUSE FOR THE REPORTED HIGH GRADIENTS WAS A COMBINATION OF PT/ PROSTHESIS MISMATCH, PRESSURE RECOVERY PHENOMENON, AND TECHNICAL APPROACH TO OBTAINING DOPPLER DURING THE ECHO. MEDTRONIC CONTINUES TO MONITOR THE FIELD PERFORMANCE TO DETECT SIMILAR EVENTS.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFO THAT THE BIOPROSTHETIC AORTIC VALVE WAS EXPLANTED AFTER APPROX 1 YEAR OF SERVICE DUE TO SYMPTOMS ASSOCIATED WITH HIGH GRADIENTS. ECHOCARDIOGRAMS INDICATE THAT THE HIGH GRADIENTS WERE CAUSED BY MODERATE PT/PROSTHESIS MISMATCH, PRESSURE RECOVERY PHENOMENON, AND OVER-TRACING OF THE SPECTRAL DOPPLER ENVELOPE. NO DEGENERATION WAS VISIBLE DURING THE ECHO, THE OPENING OF ALL THREE CUSPS WAS PROPER, THE EOA (MEASURED WITH DOPPLER) WAS 1, 2 QCM. THE INFO INDICATES THE DEVICE WAS EXPLANTED AND REPLACED WITH A STENTLESS TISSUE VALVE, WITH NO REPORTED ADVERSE PT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE LWR MEDTRONIC HEART VALVES, INC. T505 NA

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization| R